Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients

Abstract Background Specific clinical risk factors may contribute to improving or worsening neurological functions in acute ischemic stroke (AIS) patients pre-treated with a combined cholesterol reducer and recombinant tissue plasminogen activator (rtPA) therapy. In this study, clinical risk factors...

Full description

Bibliographic Details
Main Authors: Nicolas Poupore, Dan Strat, Tristan Mackey, Katherine Brown, Ashley Snell, Thomas I. Nathaniel
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Lipids in Health and Disease
Subjects:
Cholesterol reducer
NIHSS score
Neurological deficits
Thrombolytic therapy
Ischemic stroke
Online Access:http://link.springer.com/article/10.1186/s12944-020-01270-2

Internet

http://link.springer.com/article/10.1186/s12944-020-01270-2

Similar Items